InsiderTrades

Form 4 for CME CME Group

Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-15 · accession 0001628280-26-018536 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2026-03-17 2026-03-15 CME Fitzpatrick Lynne Pres, CFO A - Grant $311.40 +5,504 26.4K +26% +$1.71M
M 2026-03-17 2026-03-15 CME Fitzpatrick Lynne Pres, CFO F - Tax $311.40 -2,515 24.0K -9% -$783.2K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock Class A 2026-03-15 A A 5,504 $311.40 26,428 D — — (F1) Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.
2 Common Common Stock Class A 2026-03-15 F D 76 $311.40 23,913 D — — (F3) Ms. Fitzpatrick surrendered shares to the company to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2026.
3 Common Common Stock Class A 2026-03-15 F D 2,439 $311.40 23,989 D — — (F2) Ms. Fitzpatrick surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.